Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kimberly Tobros"'
Autor:
Alexander Montenegro, Henrique Hon, John Waldron, Christine E. Simmons, Wendy R. Parulekar, Wei Xu, Osvaldo Espin-Garcia, Kimberly Tobros, Bingshu E. Chen, Luke Harland, Ehab Fadhel, Geoffrey Liu, Yonathan Brhane, Anthony LaDelfa, Lillian L. Siu, Lawson Eng, Zahra Kassam, Sinead Cuffe
Publikováno v:
Clinical Trials. 12:237-245
Background/aims Understanding the influence or impact of epidemiological factors on cancer outcomes in clinical trials can broaden our knowledge of disease, trial populations and therapeutic effects thus leading to improved patient care. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee0d9c1587f05afe4039263742f1200e
https://doi.org/10.1177/1740774514568689
https://doi.org/10.1177/1740774514568689
Autor:
Natasha B. Leighl, Ekta Hasani, Wei Xu, Chung Kwun Amy Wong, Xin Qiu, Sohaib Masroor, Amalia M Issa, Graham McFarlane, Natalie Rozanec, Abul Kalam Azad, Henrique Hon, Sinead Cuffe, Shabbir M.H. Alibhai, Kimberly Tobros, Bradley De Souza, Geoffrey Liu
Publikováno v:
Pharmacogenetics and genomics. 24(7)
Pharmacogenomics is gaining increasing importance in the therapeutics of cancer; yet, there is little knowledge of cancer patients' attitudes toward the use of pharmacogenomic testing in clinical practice. We carried out this study to explore cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28983755c29854c4c6bca2b172438dbd
https://pubmed.ncbi.nlm.nih.gov/24911662
https://pubmed.ncbi.nlm.nih.gov/24911662
Autor:
Harman Sekhon, Paul Wheatley-Price, Frances A. Shepherd, Christina Canil, Jeffrey Sulpher, Elham Sabri, Marcio M. Gomes, S. Owen, Kimberly Tobros, Geoffrey Liu, Henrique Hon
Publikováno v:
Clinical lung cancer. 14(3)
Introduction Historically, a non–small-cell lung carcinoma diagnosis, without pathologic subclassification, provided sufficient information to guide therapy. Evidence now demonstrates that pathologic subtype classification is central in selecting o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03671b5f1428f434aba6ae49d45cbfed
https://pubmed.ncbi.nlm.nih.gov/23291255
https://pubmed.ncbi.nlm.nih.gov/23291255
Autor:
Osvaldo Espin-Garcia, Henrique Hon, Bingshu E. Chen, Geoffrey Liu, Wei Xu, Alexander Montenegro, Yonathan Brhane, Christine E. Simmons, Luke Harland, John Waldron, Wendy R. Parulekar, Lillian L. Siu, Kimberly Tobros, Lawson Eng, Zahra Kassam, Sinead Cuffe, Ehab Fadhel, Anthony LaDelfa
Publikováno v:
Journal of Clinical Oncology. 32:1586-1586
1586 Background: Understanding the influence or impact of epidemiological factors on cancer outcomes in clinical trials can broaden our knowledge of disease, trial populations and therapeutic effec...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34319d1096b2266a9409da2166f27112
https://doi.org/10.1200/jco.2014.32.15_suppl.1586
https://doi.org/10.1200/jco.2014.32.15_suppl.1586
Autor:
Bradley De Souza, Chung-Kwun Amy Wong, Nelson A. Atehortua, Ekta Hasani, Sohaib Masroor, Natalie Rozanec, Natasha B. Leighl, Wei Xu, Abul Kalam Azad, Amalia M Issa, Geoffrey Liu, Xin Qiu, Shabbir M.H. Alibhai, Henrique Hon, Sinead Cuffe, Graham McFarlane, Kimberly Tobros
Publikováno v:
Journal of Clinical Oncology. 30:13-13
13 Background: Pharmacogenomics is increasingly utilized in oncology; however, there is little knowledge concerning cancer patients’ or oncologists’ attitudes toward PGT decision-making in clinical practice. Methods: A broad cross-section of canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2719d7aa7e8b10e0a642b175f64186bd
https://doi.org/10.1200/jco.2012.30.34_suppl.13
https://doi.org/10.1200/jco.2012.30.34_suppl.13
Autor:
Sohaib Masroor, Ekta Hasani, Bradley De Souza, Wei Xu, Chung-Kwun Amy Wong, Kimberly Tobros, Geoffrey Liu, Xin Qiu, Abul Kalam Azad, Amalia M Issa, Natasha B. Leighl, Henrique Hon, Sinead Cuffe, Natalie Rozanec, Shabbir M.H. Alibhai, Graham McFarlane
Publikováno v:
Journal of Clinical Oncology. 30:6005-6005
6005 Background: PGT offers the potential to improve cancer therapy through the use of specialized tests that can predict the level of efficacy and/or toxicity of specific treatments in an individual. However, there is currently little knowledge conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abe94d80a516b373cc08bfb6b7b8b7df
https://doi.org/10.1200/jco.2012.30.15_suppl.6005
https://doi.org/10.1200/jco.2012.30.15_suppl.6005
Autor:
Elham Sabri, Henrique Hon, Paul Wheatley-Price, Frances A. Shepherd, Kimberly Tobros, S. Owen, Jeffrey Sulpher, Christina Canil, Geoffrey Liu
Publikováno v:
Journal of Clinical Oncology. 29:7541-7541
7541 Background: Non-small cell lung cancer (NSCLC) not otherwise specified (NOS) was historically sufficient information to guide systemic treatment decisions. Increasingly specific classification...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb99b44725213bf8fcff1a633ba86dc
https://doi.org/10.1200/jco.2011.29.15_suppl.7541
https://doi.org/10.1200/jco.2011.29.15_suppl.7541